Fact CheckerSign in

NCT06571344Recruiting

Vitamin D in Dialysis Patients - Diagnostic and Therapeutic Management

Source: ClinicalTrials.gov · Last updated 26 Aug 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The goal of this observational study is to learn about the effects of cholecalciferol administration, according to guidelines for the general population, on laboratory parameters of Chronic Kidney Disease-Mineral and Bone Disorder in dialysis patients, depending of the attained levels of vitamin D (25OH)D). The main question it aims to answer is: How does cholecalciferol affect calcium and phosphate metabolism parameters depending on the achieved levels of 25(OH)D? Participants taking cholecalciferol as part of their regular medical care for CKD-MBD will have the laboratory result parameters observed for up to 4 years.

Status (registry)
Recruiting
Study type
Observational
Enrollment
160 (estimated)
First submitted
22 Aug 2024
Start date
1 Nov 2022
Primary completion date
31 Dec 2026
Lead sponsor
Medical University of Gdansk
NCT number
NCT06571344

What you commit to

  • Study type: Observational
  • Planned participants: 160
  • From 1 Nov 2022 to the primary completion date, 31 Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • treatment with calcimimetics
  • treatment with active forms of vitamin D3,
  • treatment with corticosteroids

Other

  • dialysis time of less than 3 months
  • inadequately controled secondary hyperparathyroidism (iPTH\>800pg/mL)
  • parathyroidectomy
  • bilateral nephrectomy
  • lack of consent to take part in the study.

Who the study is looking for

  • CKD stage 5,dialysed patients with vitamin D deficiency or insufficiency (level of 25(OH)D \< 30 ng/mL)

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Medical University Of Gdansk
Coordinator of this site? Confirm its status
GdanskPolandRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.